Shares of Smith & Nephew plc (NYSE:SNN) rose 3.2% during trading on Wednesday . The stock traded as high as $33.54 and last traded at $34.28, approximately 54,677 shares were traded during trading. A decline of 96% from the average daily volume of 1,541,994 shares. The stock had previously closed at $33.23.
SNN has been the subject of several recent research reports. ValuEngine raised shares of Smith & Nephew from a “sell” rating to a “hold” rating in a research note on Thursday, March 5th. Zacks Investment Research lowered shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research note on Saturday, January 25th. Finally, Cfra increased their target price on shares of Smith & Nephew from $46.00 to $52.00 and gave the company a “hold” rating in a research note on Friday, February 21st. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $37.33.
The firm has a market capitalization of $14.74 billion, a price-to-earnings ratio of 16.93, a price-to-earnings-growth ratio of 2.87 and a beta of 0.30. The firm’s 50 day moving average is $42.59 and its 200 day moving average is $45.52. The company has a quick ratio of 1.03, a current ratio of 2.06 and a debt-to-equity ratio of 0.38.
A number of hedge funds have recently added to or reduced their stakes in the stock. Evoke Wealth LLC purchased a new stake in shares of Smith & Nephew in the 3rd quarter valued at approximately $25,000. Huntington National Bank lifted its position in shares of Smith & Nephew by 362.9% in the 4th quarter. Huntington National Bank now owns 787 shares of the medical equipment provider’s stock valued at $38,000 after acquiring an additional 617 shares in the last quarter. Harel Insurance Investments & Financial Services Ltd. purchased a new stake in shares of Smith & Nephew in the 4th quarter valued at approximately $38,000. NumerixS Investment Technologies Inc purchased a new stake in shares of Smith & Nephew in the 4th quarter valued at approximately $53,000. Finally, Whittier Trust Co. lifted its position in shares of Smith & Nephew by 128.6% in the 4th quarter. Whittier Trust Co. now owns 1,223 shares of the medical equipment provider’s stock valued at $59,000 after acquiring an additional 688 shares in the last quarter. 8.85% of the stock is owned by institutional investors and hedge funds.
Smith & Nephew Company Profile (NYSE:SNN)
Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.
Featured Article: S&P/ASX 200 Index
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.